Welcome to Elegant Research &Development,LLC
Transforming Promising Ideas Into Clinical Reality
About Us
Elegant offers a variety of solutions for Sponsors and CROs. (Clinical Research Organizations). We have the staff and resources needed to carry out any clinical study.
- Elegant Research is an integrated site management company with multiple research centers located throughout the U.S.
- All physicians are board-certified in their specialty and have been certified in GCP by CITI training and the National Institute of Health.
Our Goal
During our long and successful experience in clinical trials, we have worked with some of the best institutions and pharmaceutical companies such as UCLA, Duke University, GlaxoSmithKline, Sanofi Aventis, Roche,ELI LILLY and Pfizer, to bring cutting edge research to benefit our community.
Each trial is conducted under strict adherence to FDA GCPs, dedicated to a high level of protocol compliance, and responsive to critical communication between sponsor, site, IRB, study personnel, and related trial entities.
Transforming Promising Ideas Into Clinical Reality
Active Cardiovascular Studies
Phase 3, to study CSL112 (human Apolipoprotein A1) infusion in subjects with ACS .
*
HORIZON:
Impact of lipoprotein (a) lowering with TQJ230 on major CV events in patients with established cardiovascular disease.
Active Neurovascular studies
OPC-34712:
A Phase 3, 12-Week, Multicenter, Randomized, Double-blind, Placebo-controlled, 2-Arm, Fixed-dose Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer’s Type
Active Dermatology Trials
(AURORA):Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa.